Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 1, 2015, Pages 155-162

  Davis, Frank M ^a   Rateri, Debra L ^a   Balakrishnan, Anju ^a   Howatt, Deborah A ^a   Strickland, Dudley K ^b   Muratoglu, Selen C ^a   Haggerty, Christopher M ^b   Fornwalt, Brandon K ^a   Cassis, Lisa A ^a   Daugherty, Alan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; aortic aneurysm; LRP1 protein; mouse

Indexed keywords

ANGIOTENSIN II; ELASTIN; GELATINASE A; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; NORADRENALIN; SODIUM CHLORIDE; UROKINASE; LIGAND; LOW DENSITY LIPOPROTEIN RECEPTOR; LRP1 PROTEIN, MOUSE; MMP2 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ANEURYSM; ARTICLE; ASCENDING AORTA; ASCENDING AORTIC ANEURYSM; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG INFUSION; MACROPHAGE; MESENTERIC ARTERY ANEURYSM; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; SUPERIOR MESENTERIC ARTERIAL ANEURYSM; SUPERIOR MESENTERIC ARTERY; VASODILATATION; ABDOMINAL AORTA ANEURYSM; ANEURYSM; ANIMAL; ARTERIAL PRESSURE; CELL CULTURE; CHEMICALLY INDUCED; COMPARATIVE STUDY; DEFICIENCY; DISEASE MODEL; GENE DELETION; GENETICS; KNOCKOUT MOUSE; LESIONS AND DEFECTS; MALE; METABOLISM; PATHOLOGY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANEURYSM; ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM; AORTIC ANEURYSM, ABDOMINAL; ARTERIAL PRESSURE; CELLS, CULTURED; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; ELASTIN; GENE DELETION; LIGANDS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MESENTERIC ARTERY, SUPERIOR; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NOREPINEPHRINE; RECEPTORS, LDL; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84920288848     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304683     Document Type: Article

References (39)

1. Herz J, Strickland DK. LRP: a multifunctional scavenger and signaling receptor. J Clin Invest. 2001;108:779-784.
2. Strickland DK, Au DT, Cunfer P, Muratoglu SC. Low-density lipopro-tein receptor-related protein-1: role in the regulation of vascular integrity. Arterioscler Thromb Vasc Biol. 2014;34:487-498.
3. Herz J, Clouthier DE, Hammer RE. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell. 1992;71:411-421.
4. Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science. 2003;300:329-332.
5. Hu L, Boesten LS, May P, Herz J, Bovenschen N, Huisman MV, Berbée JF, Havekes LM, van Vlijmen BJ, Tamsma JT. Macrophage low-density lipoprotein receptor-related protein defciency enhances atherosclerosis in ApoE/LDLR double knockout mice. Arterioscler Thromb Vasc Biol. 2006;26:2710-2715.
6. Overton CD, Yancey PG, Major AS, Linton MF, Fazio S. Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. Circ Res. 2007;100:670-677.
7. Basford JE, Moore ZW, Zhou L, Herz J, Hui DY. Smooth muscle LDL receptor-related protein-1 inactivation reduces vascular reactivity and promotes injury-induced neointima formation. Arterioscler Thromb Vasc Biol. 2009;29:1772-1778.
8. Muratoglu SC, Belgrave S, Lillis AP, Migliorini M, Robinson S, Smith E, Zhang L, Strickland DK. Macrophage LRP1 suppresses neo-intima formation during vascular remodeling by modulating the TGF-β signaling pathway. PLoS One. 2011;6:e28846.
9. Muratoglu SC, Belgrave S, Hampton B, Migliorini M, Coksaygan T, Chen L, Mikhailenko I, Strickland DK. LRP1 protects the vasculature by regulating levels of connective tissue growth factor and HtrA1. Arterioscler Thromb Vasc Biol. 2013;33:2137-2146.
10. Basford JE, Koch S, Anjak A, Singh VP, Krause EG, Robbins N, Weintraub NL, Hui DY, Rubinstein J. Smooth muscle LDL receptor-related protein-1 deletion induces aortic insuffciency and promotes vascular cardiomyopa-thy in mice. PLoS One. 2013;8:e82026.
11. Bown MJ, Jones GT, Harrison SC, et al; CARDIoGRAM Consortium; Global BPgen Consortium; DIAGRAM Consortium; VRCNZ Consortium. Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet. 2011;89:619-627.
12. Galora S, Saracini C, Pratesi G, Sticchi E, Pulli R, Pratesi C, Abbate R, Giusti B. Association of rs1466535 LRP1 but not rs3019885 SLC30A8 and rs6674171 TDRD10 gene polymorphisms with abdominal aortic aneurysm in Italian patients. J Vasc Surg. 2014;Jan 11. pii:S0741-5214(13)01998-8.
13. Chan CY, Chan YC, Cheuk BL, Cheng SW. A pilot study on low-density lipoprotein receptor-related protein-1 in Chinese patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2013;46:549-556.
14. Li G, Yu J, Wang K, Wang B, Wang M, Zhang S, Qin S, Yu Z. Exome sequencing identifed new mutations in a Marfan syndrome family. Diagn Pathol. 2014;9:25.
15. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-defcient mice. J Clin Invest. 2000;105:1605-1612.
16. Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-defcient mice. Circulation. 2001;103:448-454.
17. Daugherty A, Rateri DL, Charo IF, Owens AP, Howatt DA, Cassis LA. Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 defciency in apoE-/-mice. Clin Sci (Lond). 2010;118:681-689.
18. Sendra J, Llorente-Cortés V, Costales P, Huesca-Gómez C, Badimon L. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension. Cardiovasc Res. 2008;78:581-589.
19. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest. 1995;95:995-1001.
20. Subramanian V, Golledge J, Heywood EB, Bruemmer D, Daugherty A. Regulation of peroxisome proliferator-activated receptor-γ by angiotensin II via transforming growth factor-β1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells. Arterioscler Thromb Vasc Biol. 2012;32:397-405.
21. Luchtefeld M, Grote K, Grothusen C, Bley S, Bandlow N, Selle T, Strüber M, Haverich A, Bavendiek U, Drexler H, Schieffer B. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun. 2005;328:183-188.
22. Iwanciw D, Rehm M, Porst M, Goppelt-Struebe M. Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways. Arterioscler Thromb Vasc Biol. 2003;23:1782-1787.
23. Cassis LA, Gupte M, Thayer S, Zhang X, Charnigo R, Howatt DA, Rateri DL, Daugherty A. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol. 2009;296:H1660-H1665.
24. Owens AP 3rd, Subramanian V, Moorleghen JJ, Guo Z, McNamara CA, Cassis LA, Daugherty A. Angiotensin II induces a region-specifc hyper-plasia of the ascending aorta through regulation of inhibitor of differentiation 3. Circ Res. 2010;106:611-619.
25. Rateri DL, Davis FM, Balakrishnan A, Howatt DA, Moorleghen JJ, O'Connor WN, Charnigo R, Cassis LA, Daugherty A. Angiotensin II induces region-specifc medial disruption during evolution of ascending aortic aneurysms. Am J Pathol. 2014;184:2586-2595.
26. Cassis LA, Rateri DL, Lu H, Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol. 2007;27:380-386.
27. Poduri A, Owens AP 3rd, Howatt DA, Moorleghen JJ, Balakrishnan A, Cassis LA, Daugherty A. Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms. PLoS One. 2012;7:e48462.
28. Daugherty A, Rateri DL, Howatt DA, Charnigo R, Cassis LA. PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism. PLoS One. 2013;8:e61849.
29. Rateri DL, Moorleghen JJ, Knight V, Balakrishnan A, Howatt DA, Cassis LA, Daugherty A. Depletion of endothelial or smooth muscle cell-specifc angiotensin II type 1a receptors does not infuence aortic aneurysms or atherosclerosis in LDL receptor defcient mice. PLoS One. 2012;7:e51483.
30. Rateri DL, Moorleghen JJ, Balakrishnan A, Owens AP 3rd, Howatt DA, Subramanian V, Poduri A, Charnigo R, Cassis LA, Daugherty A. Endothelial cell-specifc defciency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/-mice. Circ Res. 2011;108:574-581.
31. Saraff K, Babamusta F, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-defcient mice. Arterioscler Thromb Vasc Biol. 2003;23:1621-1626.
32. Tieu BC, Lee C, Sun H, Lejeune W, Recinos A 3rd, Ju X, Spratt H, Guo DC, Milewicz D, Tilton RG, Brasier AR. An adventitial IL-6/MCP1 amplifcation loop accelerates macrophage-mediated vascular infam-mation leading to aortic dissection in mice. J Clin Invest. 2009;119: 3637-3651.
33. Zhou L, Takayama Y, Boucher P, Tallquist MD, Herz J. LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PLoS One. 2009;4:e6922.
34. Senior RM, Griffn GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest. 1980;66:859-862.
35. Deng GG, Martin-McNulty B, Sukovich DA, Freay A, Halks-Miller M, Thinnes T, Loskutoff DJ, Carmeliet P, Dole WP, Wang YX. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res. 2003;92:510-517.
36. King VL, Trivedi DB, Gitlin JM, Loftin CD. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler Thromb Vasc Biol. 2006;26:1137-1143.
37. Uchida HA, Poduri A, Subramanian V, Cassis LA, Daugherty A. Urokinase-type plasminogen activator defciency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneu-rysms. Arterioscler Thromb Vasc Biol. 2011;31:2845-2852.
38. Moltzer E, Essers J, van Esch JH, Roos-Hesselink JW, Danser AH. The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications. Pharmacol Ther. 2011;131:50-60.
39. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117-121.